Objective We report our preliminary findings regarding effectiveness, safety, and tolerability of cannabidiol (CBD) added to antiepileptic therapy in a cohort of children with drug-resistant epileptic encephalopathies (EEs) with a mean follow-up of 8.5 months (range, 3-12 months). Methods A prospective cohort study was designed with the aim of…[Read more]

The nanoparticles formulated with poloxamer 188 showed better characteristics compared to the other surfactants. Conclusion This study indicates that stearic acid nanoparticles of azithromycin dihydrate prepared by high shear homogenization can be successively used for improvement of dissolution and thereby oral bioavailability of the…[Read more]

0% reported intentional and 94.0% unintentional non-adherence. Akt Inhibitor VIII Akt inhibitor Correlations between PF and adherence were small. PF did not significantly explain intentional/unintentional non-adherence after controlling for demographic and disease factors. Further clarification of the utility of PF in understanding ART…[Read more]